Quercetin: A promising phytochemical for the treatment of glioblastoma multiforme.
Clicks: 275
ID: 72694
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
79.7
/100
270 views
218 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Quercetin, a plant-derived flavonoid, is known for its antitumor and antiproliferative activities. Glioblastoma multiforme (GBM), as a highly aggressive cerebrum tumor, has a poor prognosis that is approximately 12 months despite standard therapy. Therefore, because of the low effectiveness of the current therapeutic strategies, additional medications in combination with chemotherapy and radiotherapy are needed, which could improve the prognosis of GBM patients. Multiple lines of evidence have shown that quercetin regulates many proteins involved in the cellular signal transduction in GBM. In this review, recent findings on the targeting of particular signaling pathways by quercetin and the subsequent effect on the pathogenesis of GBM are presented and discussed.
| Reference Key |
tavana2019quercetinbiofactors
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tavana, Erfan;Mollazadeh, Hamid;Mohtashami, Elmira;Modaresi, Seyed Mohamad Sadegh;Hosseini, Azar;Sabri, Hamed;Soltani, Arash;Javid, Hossein;Afshari, Amir R;Sahebkar, Amirhossein; |
| Journal | biofactors (oxford, england) |
| Year | 2019 |
| DOI |
10.1002/biof.1605
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.